Acute Myelogenous Leukemia: Genetics, Biology and Therapy by Zeev Estrov (auth.), Lalitha Nagarajan (eds.)

By Zeev Estrov (auth.), Lalitha Nagarajan (eds.)

Acute myelogenous leukemia (AML), is the most typical type of leukemia in adults. AML is a perilous kind of malignancy, the analysis for which has no longer better within the final twenty years. extra importantly, it's a malignancy that's visible in older adults, for this reason the variety of situations is probably going to upward push because the inhabitants a long time.

Over the earlier 15 years, genetic mechanisms underlying AML have started to spread. extra learn during this quarter has helped determine key parts and features. as a result, distinctive remedy of AML is receiving a lot consciousness. it's the desire of researchers that as with continual myelogenous leukemia (CML), and the drug, Gleevec, a specific remedy for AML could be discovered.

"The potent therapy of acute myelogenous leukemia continues to be a very good problem. this article experiences our realizing of the molecular and biologic foundation of the illness. major investigators handle advances in prognostication and healing techniques that experience major promise."

Steven T. Rosen, M.D.
Series Editor

Show description

Read Online or Download Acute Myelogenous Leukemia: Genetics, Biology and Therapy PDF

Similar biophysics books

Biomedical Polymers and Polymer Therapeutics

Lawsuits of the 3rd overseas Symposium on Frontiers in Biomedical Polymers together with Polymer Therapeutics: From Laboratory to medical perform, held could 23-27, 1999, in Shiga, Japan. This publication specializes in the development and precise discoveries within the interdisciplinary medical and technological region of biomedical program of polymers.

Plant Systems Biology (Annual Plant Reviews, Volume 35)

Plant structures Biology is a wonderful new addition to the more and more recognized and revered Annual Plant experiences. break up into components, this name deals the reader: A basic conceptual framework for structures Biology together with community TheoryThe development accomplished for varied version organisms:  Prokaryotes, C.

Biofunctionalization of nanomaterials (Nanotechnologies for the Life Sciences, Volume 1)

The hot e-book sequence 'Nanotechnologies for the existence Sciences' is the 1st accomplished resource at the subject matters the place fabrics technological know-how and lifestyles sciences meet at the nanoscale. each one quantity offers a concise assessment of the underlying nanotechnologies for the layout, construction and characterization of biomedical functions, collating the numerous articles present in the proper really good journals yet as but unseen by way of these operating in different disciplines.

Additional resources for Acute Myelogenous Leukemia: Genetics, Biology and Therapy

Example text

Proc Natl Acad Sci USA. 1991;88(8):3470–3474. 47. Ernst P, Wang J, Huang M, Goodman RH, Korsmeyer SJ. MLL and CREB bind cooperatively to the nuclear coactivator CREB-binding protein. Mol Cell Biol. 2001;21 (7):2249–2258. 48. Esteller M, Guo M, Moreno V, et al. Hypermethylation-associated inactivation of the cellular retinol-binding-protein 1 gene in human cancer. Cancer Res. 2002;62 (20):5902–5905. 49. Fair K, Anderson M, Bulanova E, Mi H, Tropschug M, Diaz MO. Protein interactions of the MLL PHD fingers modulate MLL target gene regulation in human cells.

1998;18(1):122–129. 142. So CW, Cleary ML. Common mechanism for oncogenic activation of MLL by forkhead family proteins. Blood. 2003;101(2):633–6739. 143. So CW, Cleary ML. MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein function. Mol Cell Biol. 2002;22(18):6542–6552. 144. Speck NA. Core binding factor and its role in normal hematopoietic development. Curr Opin Hematol. 2001;8(4):192–196. 145. Steuber CP, Holbrook T, Camitta B, Land VJ, Sexauer C, Krischer J.

Ida K, Kitabayashi I, Taki T, et al. Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22)(q23;q13). Blood. 1997;90(12):4699–4704. 36 Y. J. Issa 75. Issa JP. Aging, DNA methylation and cancer. Crit Rev Oncol Hematol. 1999;32(1):31–43. 76. Issa JP. CpG island methylator phenotype in cancer. Nat Rev Cancer. 2004;4(12): 988–993. 77. Issa JP, Garcia-Manero G, Giles FJ, et al. Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-20 -deoxycytidine (decitabine) in hematopoietic malignancies.

Download PDF sample

Rated 4.23 of 5 – based on 34 votes